nodes	percent_of_prediction	percent_of_DWPC	metapath
Haloperidol—CYP1A2—type 2 diabetes mellitus	0.123	0.602	CbGaD
Haloperidol—CYP3A4—type 2 diabetes mellitus	0.0817	0.398	CbGaD
Haloperidol—UGT1A9—Nateglinide—type 2 diabetes mellitus	0.0339	0.0665	CbGbCtD
Haloperidol—DRD4—Bromocriptine—type 2 diabetes mellitus	0.0299	0.0586	CbGbCtD
Haloperidol—HTR1D—Bromocriptine—type 2 diabetes mellitus	0.0246	0.0482	CbGbCtD
Haloperidol—HTR2B—Bromocriptine—type 2 diabetes mellitus	0.0241	0.0472	CbGbCtD
Haloperidol—HTR1B—Bromocriptine—type 2 diabetes mellitus	0.0236	0.0462	CbGbCtD
Haloperidol—DRD3—Bromocriptine—type 2 diabetes mellitus	0.0222	0.0436	CbGbCtD
Haloperidol—DRD1—Bromocriptine—type 2 diabetes mellitus	0.0214	0.042	CbGbCtD
Haloperidol—HTR2A—Bromocriptine—type 2 diabetes mellitus	0.0141	0.0277	CbGbCtD
Haloperidol—DRD2—Bromocriptine—type 2 diabetes mellitus	0.013	0.0255	CbGbCtD
Haloperidol—CYP3A7—Nateglinide—type 2 diabetes mellitus	0.0113	0.0221	CbGbCtD
Haloperidol—CYP3A7-CYP3A51P—Nateglinide—type 2 diabetes mellitus	0.0113	0.0221	CbGbCtD
Haloperidol—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0113	0.0221	CbGbCtD
Haloperidol—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0106	0.0207	CbGbCtD
Haloperidol—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0103	0.0203	CbGbCtD
Haloperidol—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.01	0.0197	CbGbCtD
Haloperidol—CYP2C9—Glipizide—type 2 diabetes mellitus	0.00945	0.0185	CbGbCtD
Haloperidol—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.00899	0.0176	CbGbCtD
Haloperidol—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.00899	0.0176	CbGbCtD
Haloperidol—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.00879	0.0172	CbGbCtD
Haloperidol—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.00844	0.0166	CbGbCtD
Haloperidol—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.00829	0.0163	CbGbCtD
Haloperidol—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.00801	0.0157	CbGbCtD
Haloperidol—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.00765	0.015	CbGbCtD
Haloperidol—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.00747	0.0147	CbGbCtD
Haloperidol—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.00747	0.0147	CbGbCtD
Haloperidol—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00725	0.0142	CbGbCtD
Haloperidol—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.00689	0.0135	CbGbCtD
Haloperidol—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00683	0.0134	CbGbCtD
Haloperidol—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00674	0.0132	CbGbCtD
Haloperidol—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00666	0.0131	CbGbCtD
Haloperidol—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0063	0.0124	CbGbCtD
Haloperidol—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00609	0.012	CbGbCtD
Haloperidol—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.00602	0.0118	CbGbCtD
Haloperidol—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00601	0.0118	CbGbCtD
Haloperidol—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0057	0.0112	CbGbCtD
Haloperidol—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00566	0.0111	CbGbCtD
Haloperidol—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0055	0.0108	CbGbCtD
Haloperidol—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00543	0.0107	CbGbCtD
Haloperidol—CYP3A5—Losartan—type 2 diabetes mellitus	0.00522	0.0102	CbGbCtD
Haloperidol—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00518	0.0102	CbGbCtD
Haloperidol—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00498	0.00978	CbGbCtD
Haloperidol—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00496	0.00974	CbGbCtD
Haloperidol—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0048	0.00943	CbGbCtD
Haloperidol—CYP2C19—Glyburide—type 2 diabetes mellitus	0.0046	0.00903	CbGbCtD
Haloperidol—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00434	0.00853	CbGbCtD
Haloperidol—CYP2C19—Losartan—type 2 diabetes mellitus	0.00421	0.00826	CbGbCtD
Haloperidol—CYP1A2—Losartan—type 2 diabetes mellitus	0.00388	0.00762	CbGbCtD
Haloperidol—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00382	0.00751	CbGbCtD
Haloperidol—ABCB1—Glyburide—type 2 diabetes mellitus	0.00371	0.00728	CbGbCtD
Haloperidol—CYP2C9—Losartan—type 2 diabetes mellitus	0.0035	0.00687	CbGbCtD
Haloperidol—ABCB1—Losartan—type 2 diabetes mellitus	0.00339	0.00666	CbGbCtD
Haloperidol—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00329	0.00646	CbGbCtD
Haloperidol—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00316	0.00619	CbGbCtD
Haloperidol—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00316	0.00619	CbGbCtD
Haloperidol—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00298	0.00586	CbGbCtD
Haloperidol—GRIN2B—nerve—type 2 diabetes mellitus	0.00226	0.0609	CbGeAlD
Haloperidol—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00222	0.00436	CbGbCtD
Haloperidol—HTR2A—arteriole—type 2 diabetes mellitus	0.00219	0.0591	CbGeAlD
Haloperidol—CYP3A4—Losartan—type 2 diabetes mellitus	0.00203	0.00399	CbGbCtD
Haloperidol—HTR2A—sympathetic nervous system—type 2 diabetes mellitus	0.0014	0.0377	CbGeAlD
Haloperidol—DRD1—nerve—type 2 diabetes mellitus	0.00136	0.0366	CbGeAlD
Haloperidol—HTR1B—artery—type 2 diabetes mellitus	0.00111	0.0299	CbGeAlD
Haloperidol—HTR1D—artery—type 2 diabetes mellitus	0.00107	0.0289	CbGeAlD
Haloperidol—EBP—Bortezomib—Nateglinide—type 2 diabetes mellitus	0.000985	1	CbGdCrCtD
Haloperidol—HTR2A—autonomic nervous system—type 2 diabetes mellitus	0.000939	0.0253	CbGeAlD
Haloperidol—HTR2A—hindlimb—type 2 diabetes mellitus	0.000869	0.0234	CbGeAlD
Haloperidol—CBR1—islet of Langerhans—type 2 diabetes mellitus	0.000812	0.0219	CbGeAlD
Haloperidol—DRD2—nerve—type 2 diabetes mellitus	0.000801	0.0216	CbGeAlD
Haloperidol—EBP—liver—type 2 diabetes mellitus	0.000796	0.0215	CbGeAlD
Haloperidol—UGT1A9—kidney—type 2 diabetes mellitus	0.000763	0.0206	CbGeAlD
Haloperidol—HTR2A—peripheral nervous system—type 2 diabetes mellitus	0.000678	0.0183	CbGeAlD
Haloperidol—H1F0—islet of Langerhans—type 2 diabetes mellitus	0.000665	0.0179	CbGeAlD
Haloperidol—CBR1—nephron tubule—type 2 diabetes mellitus	0.000654	0.0176	CbGeAlD
Haloperidol—CYP3A7-CYP3A51P—nephron tubule—type 2 diabetes mellitus	0.000614	0.0166	CbGeAlD
Haloperidol—CBR1—cardiovascular system—type 2 diabetes mellitus	0.000587	0.0158	CbGeAlD
Haloperidol—CBR1—kidney—type 2 diabetes mellitus	0.000574	0.0155	CbGeAlD
Haloperidol—H1F0—retina—type 2 diabetes mellitus	0.000569	0.0153	CbGeAlD
Haloperidol—CBR1—cortex of kidney—type 2 diabetes mellitus	0.000559	0.0151	CbGeAlD
Haloperidol—H1F0—nephron tubule—type 2 diabetes mellitus	0.000536	0.0144	CbGeAlD
Haloperidol—HTR2A—artery—type 2 diabetes mellitus	0.000533	0.0144	CbGeAlD
Haloperidol—HTR2A—nerve—type 2 diabetes mellitus	0.000528	0.0142	CbGeAlD
Haloperidol—CYP3A7-CYP3A51P—cortex of kidney—type 2 diabetes mellitus	0.000526	0.0142	CbGeAlD
Haloperidol—CBR1—adipose tissue—type 2 diabetes mellitus	0.000518	0.014	CbGeAlD
Haloperidol—UGT1A9—liver—type 2 diabetes mellitus	0.000482	0.013	CbGeAlD
Haloperidol—H1F0—cardiovascular system—type 2 diabetes mellitus	0.000481	0.013	CbGeAlD
Haloperidol—SIGMAR1—islet of Langerhans—type 2 diabetes mellitus	0.00048	0.013	CbGeAlD
Haloperidol—H1F0—kidney—type 2 diabetes mellitus	0.000471	0.0127	CbGeAlD
Haloperidol—H1F0—pancreas—type 2 diabetes mellitus	0.000468	0.0126	CbGeAlD
Haloperidol—H1F0—cortex of kidney—type 2 diabetes mellitus	0.000458	0.0124	CbGeAlD
Haloperidol—HTR2A—endothelium—type 2 diabetes mellitus	0.00045	0.0121	CbGeAlD
Haloperidol—Loperamide—CALM1—type 2 diabetes mellitus	0.000429	0.205	CrCbGaD
Haloperidol—H1F0—adipose tissue—type 2 diabetes mellitus	0.000424	0.0114	CbGeAlD
Haloperidol—CYP3A7—liver—type 2 diabetes mellitus	0.000401	0.0108	CbGeAlD
Haloperidol—SIGMAR1—nephron tubule—type 2 diabetes mellitus	0.000387	0.0104	CbGeAlD
Haloperidol—HTR1B—cardiovascular system—type 2 diabetes mellitus	0.000385	0.0104	CbGeAlD
Haloperidol—KCNH2—islet of Langerhans—type 2 diabetes mellitus	0.000382	0.0103	CbGeAlD
Haloperidol—Sertindole—ADRA2A—type 2 diabetes mellitus	0.000382	0.183	CrCbGaD
Haloperidol—HTR1D—cardiovascular system—type 2 diabetes mellitus	0.000373	0.01	CbGeAlD
Haloperidol—HTR1D—kidney—type 2 diabetes mellitus	0.000365	0.00983	CbGeAlD
Haloperidol—CBR1—liver—type 2 diabetes mellitus	0.000363	0.00979	CbGeAlD
Haloperidol—Sertindole—HTR2C—type 2 diabetes mellitus	0.000351	0.168	CrCbGaD
Haloperidol—Moclobemide—CYP1A2—type 2 diabetes mellitus	0.00035	0.168	CrCbGaD
Haloperidol—HTR2B—cardiovascular system—type 2 diabetes mellitus	0.000347	0.00935	CbGeAlD
Haloperidol—CYP3A7-CYP3A51P—liver—type 2 diabetes mellitus	0.000341	0.0092	CbGeAlD
Haloperidol—SIGMAR1—pancreas—type 2 diabetes mellitus	0.000338	0.00911	CbGeAlD
Haloperidol—DRD2—retina—type 2 diabetes mellitus	0.000332	0.00895	CbGeAlD
Haloperidol—SIGMAR1—cortex of kidney—type 2 diabetes mellitus	0.000331	0.00893	CbGeAlD
Haloperidol—HTR2B—cortex of kidney—type 2 diabetes mellitus	0.00033	0.00891	CbGeAlD
Haloperidol—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	0.000316	0.00851	CbGeAlD
Haloperidol—Fluspirilene—ADRA2A—type 2 diabetes mellitus	0.000311	0.149	CrCbGaD
Haloperidol—SIGMAR1—adipose tissue—type 2 diabetes mellitus	0.000306	0.00826	CbGeAlD
Haloperidol—HTR2B—adipose tissue—type 2 diabetes mellitus	0.000306	0.00824	CbGeAlD
Haloperidol—H1F0—liver—type 2 diabetes mellitus	0.000297	0.00802	CbGeAlD
Haloperidol—KCNH2—cardiovascular system—type 2 diabetes mellitus	0.000277	0.00746	CbGeAlD
Haloperidol—CYP3A5—nephron tubule—type 2 diabetes mellitus	0.000254	0.00686	CbGeAlD
Haloperidol—CYP1A1—kidney—type 2 diabetes mellitus	0.000228	0.00616	CbGeAlD
Haloperidol—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000225	0.00606	CbGeAlD
Haloperidol—CYP3A5—kidney—type 2 diabetes mellitus	0.000223	0.00602	CbGeAlD
Haloperidol—CYP3A5—pancreas—type 2 diabetes mellitus	0.000222	0.00599	CbGeAlD
Haloperidol—HTR2A—retina—type 2 diabetes mellitus	0.000219	0.0059	CbGeAlD
Haloperidol—CYP3A5—cortex of kidney—type 2 diabetes mellitus	0.000218	0.00587	CbGeAlD
Haloperidol—SIGMAR1—liver—type 2 diabetes mellitus	0.000215	0.00579	CbGeAlD
Haloperidol—CYP1A1—adipose tissue—type 2 diabetes mellitus	0.000206	0.00555	CbGeAlD
Haloperidol—CYP3A5—adipose tissue—type 2 diabetes mellitus	0.000201	0.00543	CbGeAlD
Haloperidol—HRH1—adipose tissue—type 2 diabetes mellitus	0.000195	0.00527	CbGeAlD
Haloperidol—HTR2A—cardiovascular system—type 2 diabetes mellitus	0.000185	0.00499	CbGeAlD
Haloperidol—HTR2A—kidney—type 2 diabetes mellitus	0.000181	0.00488	CbGeAlD
Haloperidol—CYP2C19—liver—type 2 diabetes mellitus	0.000179	0.00483	CbGeAlD
Haloperidol—Sertindole—CYP3A4—type 2 diabetes mellitus	0.000176	0.0841	CrCbGaD
Haloperidol—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000168	0.00452	CbGeAlD
Haloperidol—CYP3A4—kidney—type 2 diabetes mellitus	0.000168	0.00452	CbGeAlD
Haloperidol—CYP2D6—kidney—type 2 diabetes mellitus	0.000165	0.00445	CbGeAlD
Haloperidol—CYP1A2—liver—type 2 diabetes mellitus	0.000146	0.00395	CbGeAlD
Haloperidol—CYP1A1—liver—type 2 diabetes mellitus	0.000144	0.00389	CbGeAlD
Haloperidol—ABCB1—retina—type 2 diabetes mellitus	0.000143	0.00387	CbGeAlD
Haloperidol—CYP3A5—liver—type 2 diabetes mellitus	0.000141	0.00381	CbGeAlD
Haloperidol—CYP2C9—liver—type 2 diabetes mellitus	0.000139	0.00375	CbGeAlD
Haloperidol—ABCB1—nephron tubule—type 2 diabetes mellitus	0.000135	0.00364	CbGeAlD
Haloperidol—ABCB1—cardiovascular system—type 2 diabetes mellitus	0.000121	0.00327	CbGeAlD
Haloperidol—ABCB1—kidney—type 2 diabetes mellitus	0.000119	0.0032	CbGeAlD
Haloperidol—ABCB1—pancreas—type 2 diabetes mellitus	0.000118	0.00318	CbGeAlD
Haloperidol—ABCB1—cortex of kidney—type 2 diabetes mellitus	0.000116	0.00312	CbGeAlD
Haloperidol—HTR2A—liver—type 2 diabetes mellitus	0.000114	0.00309	CbGeAlD
Haloperidol—ABCB1—adipose tissue—type 2 diabetes mellitus	0.000107	0.00288	CbGeAlD
Haloperidol—CYP3A4—liver—type 2 diabetes mellitus	0.000106	0.00286	CbGeAlD
Haloperidol—CYP2D6—liver—type 2 diabetes mellitus	0.000104	0.00281	CbGeAlD
Haloperidol—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000101	0.000692	CcSEcCtD
Haloperidol—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.0001	0.00069	CcSEcCtD
Haloperidol—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.0001	0.000689	CcSEcCtD
Haloperidol—Dry mouth—Orlistat—type 2 diabetes mellitus	9.98e-05	0.000686	CcSEcCtD
Haloperidol—Alopecia—Losartan—type 2 diabetes mellitus	9.96e-05	0.000684	CcSEcCtD
Haloperidol—Diarrhoea—Glimepiride—type 2 diabetes mellitus	9.96e-05	0.000684	CcSEcCtD
Haloperidol—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	9.93e-05	0.000682	CcSEcCtD
Haloperidol—Vomiting—Glipizide—type 2 diabetes mellitus	9.92e-05	0.000681	CcSEcCtD
Haloperidol—Oedema—Valsartan—type 2 diabetes mellitus	9.9e-05	0.00068	CcSEcCtD
Haloperidol—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	9.9e-05	0.00068	CcSEcCtD
Haloperidol—Feeling abnormal—Glyburide—type 2 diabetes mellitus	9.89e-05	0.00068	CcSEcCtD
Haloperidol—Dizziness—Pioglitazone—type 2 diabetes mellitus	9.88e-05	0.000679	CcSEcCtD
Haloperidol—Rash—Glipizide—type 2 diabetes mellitus	9.83e-05	0.000676	CcSEcCtD
Haloperidol—Vision blurred—Irbesartan—type 2 diabetes mellitus	9.83e-05	0.000675	CcSEcCtD
Haloperidol—Dermatitis—Glipizide—type 2 diabetes mellitus	9.83e-05	0.000675	CcSEcCtD
Haloperidol—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	9.79e-05	0.000672	CcSEcCtD
Haloperidol—Oedema—Orlistat—type 2 diabetes mellitus	9.79e-05	0.000672	CcSEcCtD
Haloperidol—Headache—Glipizide—type 2 diabetes mellitus	9.77e-05	0.000671	CcSEcCtD
Haloperidol—Tremor—Irbesartan—type 2 diabetes mellitus	9.77e-05	0.000671	CcSEcCtD
Haloperidol—Insomnia—Gliclazide—type 2 diabetes mellitus	9.75e-05	0.00067	CcSEcCtD
Haloperidol—Nervous system disorder—Valsartan—type 2 diabetes mellitus	9.71e-05	0.000667	CcSEcCtD
Haloperidol—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	9.7e-05	0.000666	CcSEcCtD
Haloperidol—Hepatitis—Ramipril—type 2 diabetes mellitus	9.67e-05	0.000664	CcSEcCtD
Haloperidol—Anaemia—Irbesartan—type 2 diabetes mellitus	9.64e-05	0.000662	CcSEcCtD
Haloperidol—Dizziness—Glimepiride—type 2 diabetes mellitus	9.63e-05	0.000661	CcSEcCtD
Haloperidol—Skin disorder—Valsartan—type 2 diabetes mellitus	9.62e-05	0.000661	CcSEcCtD
Haloperidol—Dyspnoea—Gliclazide—type 2 diabetes mellitus	9.61e-05	0.00066	CcSEcCtD
Haloperidol—Nervous system disorder—Orlistat—type 2 diabetes mellitus	9.6e-05	0.000659	CcSEcCtD
Haloperidol—Dizziness—Sitagliptin—type 2 diabetes mellitus	9.59e-05	0.000659	CcSEcCtD
Haloperidol—Agitation—Irbesartan—type 2 diabetes mellitus	9.58e-05	0.000658	CcSEcCtD
Haloperidol—Somnolence—Gliclazide—type 2 diabetes mellitus	9.58e-05	0.000658	CcSEcCtD
Haloperidol—Hypertension—Metformin—type 2 diabetes mellitus	9.54e-05	0.000655	CcSEcCtD
Haloperidol—Urticaria—Glyburide—type 2 diabetes mellitus	9.54e-05	0.000655	CcSEcCtD
Haloperidol—Skin disorder—Orlistat—type 2 diabetes mellitus	9.5e-05	0.000653	CcSEcCtD
Haloperidol—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	9.5e-05	0.000653	CcSEcCtD
Haloperidol—Dyspepsia—Gliclazide—type 2 diabetes mellitus	9.49e-05	0.000652	CcSEcCtD
Haloperidol—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	9.46e-05	0.00065	CcSEcCtD
Haloperidol—Anorexia—Valsartan—type 2 diabetes mellitus	9.44e-05	0.000649	CcSEcCtD
Haloperidol—Muscle spasms—Losartan—type 2 diabetes mellitus	9.44e-05	0.000648	CcSEcCtD
Haloperidol—Vertigo—Irbesartan—type 2 diabetes mellitus	9.37e-05	0.000644	CcSEcCtD
Haloperidol—Headache—Pioglitazone—type 2 diabetes mellitus	9.36e-05	0.000643	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	9.34e-05	0.000642	CcSEcCtD
Haloperidol—Leukopenia—Irbesartan—type 2 diabetes mellitus	9.33e-05	0.000641	CcSEcCtD
Haloperidol—Visual impairment—Ramipril—type 2 diabetes mellitus	9.32e-05	0.00064	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	9.31e-05	0.000639	CcSEcCtD
Haloperidol—Nausea—Glipizide—type 2 diabetes mellitus	9.26e-05	0.000637	CcSEcCtD
Haloperidol—Vomiting—Glimepiride—type 2 diabetes mellitus	9.25e-05	0.000636	CcSEcCtD
Haloperidol—Hypotension—Valsartan—type 2 diabetes mellitus	9.25e-05	0.000636	CcSEcCtD
Haloperidol—Vision blurred—Losartan—type 2 diabetes mellitus	9.25e-05	0.000635	CcSEcCtD
Haloperidol—Vomiting—Sitagliptin—type 2 diabetes mellitus	9.23e-05	0.000634	CcSEcCtD
Haloperidol—Constipation—Gliclazide—type 2 diabetes mellitus	9.22e-05	0.000633	CcSEcCtD
Haloperidol—Tremor—Losartan—type 2 diabetes mellitus	9.19e-05	0.000632	CcSEcCtD
Haloperidol—Rash—Glimepiride—type 2 diabetes mellitus	9.18e-05	0.000631	CcSEcCtD
Haloperidol—Dermatitis—Glimepiride—type 2 diabetes mellitus	9.17e-05	0.00063	CcSEcCtD
Haloperidol—Rash—Sitagliptin—type 2 diabetes mellitus	9.15e-05	0.000629	CcSEcCtD
Haloperidol—Dermatitis—Sitagliptin—type 2 diabetes mellitus	9.14e-05	0.000628	CcSEcCtD
Haloperidol—Headache—Glimepiride—type 2 diabetes mellitus	9.12e-05	0.000627	CcSEcCtD
Haloperidol—Headache—Sitagliptin—type 2 diabetes mellitus	9.09e-05	0.000625	CcSEcCtD
Haloperidol—Anaemia—Losartan—type 2 diabetes mellitus	9.07e-05	0.000623	CcSEcCtD
Haloperidol—Agitation—Losartan—type 2 diabetes mellitus	9.02e-05	0.00062	CcSEcCtD
Haloperidol—Oedema—Metformin—type 2 diabetes mellitus	9.02e-05	0.00062	CcSEcCtD
Haloperidol—Hypertension—Irbesartan—type 2 diabetes mellitus	9e-05	0.000619	CcSEcCtD
Haloperidol—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	8.98e-05	0.000617	CcSEcCtD
Haloperidol—Insomnia—Valsartan—type 2 diabetes mellitus	8.96e-05	0.000615	CcSEcCtD
Haloperidol—Loperamide—CYP3A4—type 2 diabetes mellitus	8.93e-05	0.0428	CrCbGaD
Haloperidol—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	8.88e-05	0.00061	CcSEcCtD
Haloperidol—Insomnia—Orlistat—type 2 diabetes mellitus	8.85e-05	0.000608	CcSEcCtD
Haloperidol—Anxiety—Irbesartan—type 2 diabetes mellitus	8.85e-05	0.000608	CcSEcCtD
Haloperidol—Hypersensitivity—Glyburide—type 2 diabetes mellitus	8.84e-05	0.000608	CcSEcCtD
Haloperidol—Nervous system disorder—Metformin—type 2 diabetes mellitus	8.84e-05	0.000608	CcSEcCtD
Haloperidol—Thrombocytopenia—Metformin—type 2 diabetes mellitus	8.83e-05	0.000607	CcSEcCtD
Haloperidol—Dyspnoea—Valsartan—type 2 diabetes mellitus	8.83e-05	0.000607	CcSEcCtD
Haloperidol—Vertigo—Losartan—type 2 diabetes mellitus	8.82e-05	0.000606	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	8.82e-05	0.000606	CcSEcCtD
Haloperidol—Somnolence—Valsartan—type 2 diabetes mellitus	8.8e-05	0.000605	CcSEcCtD
Haloperidol—Leukopenia—Losartan—type 2 diabetes mellitus	8.78e-05	0.000604	CcSEcCtD
Haloperidol—Skin disorder—Metformin—type 2 diabetes mellitus	8.76e-05	0.000602	CcSEcCtD
Haloperidol—Immune system disorder—Ramipril—type 2 diabetes mellitus	8.73e-05	0.0006	CcSEcCtD
Haloperidol—Hyperhidrosis—Metformin—type 2 diabetes mellitus	8.72e-05	0.000599	CcSEcCtD
Haloperidol—Dyspepsia—Valsartan—type 2 diabetes mellitus	8.72e-05	0.000599	CcSEcCtD
Haloperidol—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	8.71e-05	0.000599	CcSEcCtD
Haloperidol—Dizziness—Bromocriptine—type 2 diabetes mellitus	8.68e-05	0.000597	CcSEcCtD
Haloperidol—Dry mouth—Irbesartan—type 2 diabetes mellitus	8.68e-05	0.000597	CcSEcCtD
Haloperidol—Nausea—Glimepiride—type 2 diabetes mellitus	8.65e-05	0.000594	CcSEcCtD
Haloperidol—Nausea—Sitagliptin—type 2 diabetes mellitus	8.62e-05	0.000592	CcSEcCtD
Haloperidol—Dyspepsia—Orlistat—type 2 diabetes mellitus	8.61e-05	0.000592	CcSEcCtD
Haloperidol—Decreased appetite—Valsartan—type 2 diabetes mellitus	8.61e-05	0.000591	CcSEcCtD
Haloperidol—Anorexia—Metformin—type 2 diabetes mellitus	8.6e-05	0.000591	CcSEcCtD
Haloperidol—Urticaria—Gliclazide—type 2 diabetes mellitus	8.56e-05	0.000588	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	8.55e-05	0.000587	CcSEcCtD
Haloperidol—Alopecia—Ramipril—type 2 diabetes mellitus	8.54e-05	0.000587	CcSEcCtD
Haloperidol—Body temperature increased—Gliclazide—type 2 diabetes mellitus	8.52e-05	0.000585	CcSEcCtD
Haloperidol—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	8.51e-05	0.000585	CcSEcCtD
Haloperidol—Oedema—Irbesartan—type 2 diabetes mellitus	8.51e-05	0.000585	CcSEcCtD
Haloperidol—Decreased appetite—Orlistat—type 2 diabetes mellitus	8.51e-05	0.000584	CcSEcCtD
Haloperidol—Pruritus—Glyburide—type 2 diabetes mellitus	8.49e-05	0.000584	CcSEcCtD
Haloperidol—Mental disorder—Ramipril—type 2 diabetes mellitus	8.47e-05	0.000582	CcSEcCtD
Haloperidol—Constipation—Valsartan—type 2 diabetes mellitus	8.47e-05	0.000582	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	8.45e-05	0.00058	CcSEcCtD
Haloperidol—Hypotension—Metformin—type 2 diabetes mellitus	8.43e-05	0.000579	CcSEcCtD
Haloperidol—Malnutrition—Ramipril—type 2 diabetes mellitus	8.41e-05	0.000578	CcSEcCtD
Haloperidol—Vomiting—Bromocriptine—type 2 diabetes mellitus	8.35e-05	0.000574	CcSEcCtD
Haloperidol—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	8.35e-05	0.000573	CcSEcCtD
Haloperidol—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	8.33e-05	0.000573	CcSEcCtD
Haloperidol—Anxiety—Losartan—type 2 diabetes mellitus	8.33e-05	0.000572	CcSEcCtD
Haloperidol—Tachycardia—Irbesartan—type 2 diabetes mellitus	8.31e-05	0.000571	CcSEcCtD
Haloperidol—Rash—Bromocriptine—type 2 diabetes mellitus	8.28e-05	0.000569	CcSEcCtD
Haloperidol—Dermatitis—Bromocriptine—type 2 diabetes mellitus	8.27e-05	0.000568	CcSEcCtD
Haloperidol—Skin disorder—Irbesartan—type 2 diabetes mellitus	8.27e-05	0.000568	CcSEcCtD
Haloperidol—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	8.23e-05	0.000565	CcSEcCtD
Haloperidol—Headache—Bromocriptine—type 2 diabetes mellitus	8.23e-05	0.000565	CcSEcCtD
Haloperidol—Diarrhoea—Glyburide—type 2 diabetes mellitus	8.21e-05	0.000564	CcSEcCtD
Haloperidol—Dry mouth—Losartan—type 2 diabetes mellitus	8.17e-05	0.000561	CcSEcCtD
Haloperidol—Anorexia—Irbesartan—type 2 diabetes mellitus	8.11e-05	0.000557	CcSEcCtD
Haloperidol—Muscle spasms—Ramipril—type 2 diabetes mellitus	8.09e-05	0.000556	CcSEcCtD
Haloperidol—Confusional state—Losartan—type 2 diabetes mellitus	8.08e-05	0.000555	CcSEcCtD
Haloperidol—Feeling abnormal—Orlistat—type 2 diabetes mellitus	8.06e-05	0.000554	CcSEcCtD
Haloperidol—Dyspnoea—Metformin—type 2 diabetes mellitus	8.04e-05	0.000552	CcSEcCtD
Haloperidol—Somnolence—Metformin—type 2 diabetes mellitus	8.02e-05	0.000551	CcSEcCtD
Haloperidol—Anaphylactic shock—Losartan—type 2 diabetes mellitus	8.01e-05	0.00055	CcSEcCtD
Haloperidol—Oedema—Losartan—type 2 diabetes mellitus	8.01e-05	0.00055	CcSEcCtD
Haloperidol—Hypotension—Irbesartan—type 2 diabetes mellitus	7.95e-05	0.000546	CcSEcCtD
Haloperidol—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	7.94e-05	0.000546	CcSEcCtD
Haloperidol—Dyspepsia—Metformin—type 2 diabetes mellitus	7.94e-05	0.000545	CcSEcCtD
Haloperidol—Tremor—Ramipril—type 2 diabetes mellitus	7.88e-05	0.000542	CcSEcCtD
Haloperidol—Urticaria—Valsartan—type 2 diabetes mellitus	7.87e-05	0.000541	CcSEcCtD
Haloperidol—Nervous system disorder—Losartan—type 2 diabetes mellitus	7.85e-05	0.00054	CcSEcCtD
Haloperidol—Thrombocytopenia—Losartan—type 2 diabetes mellitus	7.84e-05	0.000539	CcSEcCtD
Haloperidol—Decreased appetite—Metformin—type 2 diabetes mellitus	7.84e-05	0.000539	CcSEcCtD
Haloperidol—Tachycardia—Losartan—type 2 diabetes mellitus	7.82e-05	0.000537	CcSEcCtD
Haloperidol—Nausea—Bromocriptine—type 2 diabetes mellitus	7.8e-05	0.000536	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	7.79e-05	0.000535	CcSEcCtD
Haloperidol—Urticaria—Orlistat—type 2 diabetes mellitus	7.77e-05	0.000534	CcSEcCtD
Haloperidol—Hyperhidrosis—Losartan—type 2 diabetes mellitus	7.74e-05	0.000532	CcSEcCtD
Haloperidol—Body temperature increased—Orlistat—type 2 diabetes mellitus	7.74e-05	0.000532	CcSEcCtD
Haloperidol—Agitation—Ramipril—type 2 diabetes mellitus	7.73e-05	0.000531	CcSEcCtD
Haloperidol—Constipation—Metformin—type 2 diabetes mellitus	7.71e-05	0.00053	CcSEcCtD
Haloperidol—Anorexia—Losartan—type 2 diabetes mellitus	7.63e-05	0.000525	CcSEcCtD
Haloperidol—Vomiting—Glyburide—type 2 diabetes mellitus	7.63e-05	0.000524	CcSEcCtD
Haloperidol—Pruritus—Gliclazide—type 2 diabetes mellitus	7.63e-05	0.000524	CcSEcCtD
Haloperidol—Dyspnoea—Irbesartan—type 2 diabetes mellitus	7.59e-05	0.000521	CcSEcCtD
Haloperidol—Rash—Glyburide—type 2 diabetes mellitus	7.57e-05	0.00052	CcSEcCtD
Haloperidol—Somnolence—Irbesartan—type 2 diabetes mellitus	7.57e-05	0.00052	CcSEcCtD
Haloperidol—Dermatitis—Glyburide—type 2 diabetes mellitus	7.56e-05	0.00052	CcSEcCtD
Haloperidol—Vertigo—Ramipril—type 2 diabetes mellitus	7.56e-05	0.000519	CcSEcCtD
Haloperidol—Leukopenia—Ramipril—type 2 diabetes mellitus	7.53e-05	0.000518	CcSEcCtD
Haloperidol—Headache—Glyburide—type 2 diabetes mellitus	7.52e-05	0.000517	CcSEcCtD
Haloperidol—ABCB1—liver—type 2 diabetes mellitus	7.5e-05	0.00202	CbGeAlD
Haloperidol—Dyspepsia—Irbesartan—type 2 diabetes mellitus	7.49e-05	0.000515	CcSEcCtD
Haloperidol—Hypotension—Losartan—type 2 diabetes mellitus	7.48e-05	0.000514	CcSEcCtD
Haloperidol—Feeling abnormal—Metformin—type 2 diabetes mellitus	7.43e-05	0.000511	CcSEcCtD
Haloperidol—Decreased appetite—Irbesartan—type 2 diabetes mellitus	7.4e-05	0.000508	CcSEcCtD
Haloperidol—Diarrhoea—Gliclazide—type 2 diabetes mellitus	7.37e-05	0.000507	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	7.35e-05	0.000505	CcSEcCtD
Haloperidol—Hypersensitivity—Valsartan—type 2 diabetes mellitus	7.3e-05	0.000501	CcSEcCtD
Haloperidol—Convulsion—Ramipril—type 2 diabetes mellitus	7.29e-05	0.000501	CcSEcCtD
Haloperidol—Constipation—Irbesartan—type 2 diabetes mellitus	7.28e-05	0.0005	CcSEcCtD
Haloperidol—Insomnia—Losartan—type 2 diabetes mellitus	7.24e-05	0.000498	CcSEcCtD
Haloperidol—Hypersensitivity—Orlistat—type 2 diabetes mellitus	7.21e-05	0.000495	CcSEcCtD
Haloperidol—Urticaria—Metformin—type 2 diabetes mellitus	7.16e-05	0.000492	CcSEcCtD
Haloperidol—Dyspnoea—Losartan—type 2 diabetes mellitus	7.14e-05	0.000491	CcSEcCtD
Haloperidol—Anxiety—Ramipril—type 2 diabetes mellitus	7.14e-05	0.000491	CcSEcCtD
Haloperidol—Nausea—Glyburide—type 2 diabetes mellitus	7.13e-05	0.00049	CcSEcCtD
Haloperidol—Dizziness—Gliclazide—type 2 diabetes mellitus	7.13e-05	0.00049	CcSEcCtD
Haloperidol—Somnolence—Losartan—type 2 diabetes mellitus	7.12e-05	0.000489	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	7.11e-05	0.000489	CcSEcCtD
Haloperidol—Dyspepsia—Losartan—type 2 diabetes mellitus	7.05e-05	0.000484	CcSEcCtD
Haloperidol—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	7.01e-05	0.000482	CcSEcCtD
Haloperidol—Pruritus—Valsartan—type 2 diabetes mellitus	7.01e-05	0.000481	CcSEcCtD
Haloperidol—Dry mouth—Ramipril—type 2 diabetes mellitus	7.01e-05	0.000481	CcSEcCtD
Haloperidol—Decreased appetite—Losartan—type 2 diabetes mellitus	6.96e-05	0.000478	CcSEcCtD
Haloperidol—Confusional state—Ramipril—type 2 diabetes mellitus	6.92e-05	0.000476	CcSEcCtD
Haloperidol—Pruritus—Orlistat—type 2 diabetes mellitus	6.92e-05	0.000476	CcSEcCtD
Haloperidol—Oedema—Ramipril—type 2 diabetes mellitus	6.87e-05	0.000472	CcSEcCtD
Haloperidol—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	6.87e-05	0.000472	CcSEcCtD
Haloperidol—Vomiting—Gliclazide—type 2 diabetes mellitus	6.85e-05	0.000471	CcSEcCtD
Haloperidol—Constipation—Losartan—type 2 diabetes mellitus	6.85e-05	0.000471	CcSEcCtD
Haloperidol—Rash—Gliclazide—type 2 diabetes mellitus	6.8e-05	0.000467	CcSEcCtD
Haloperidol—Dermatitis—Gliclazide—type 2 diabetes mellitus	6.79e-05	0.000467	CcSEcCtD
Haloperidol—Diarrhoea—Valsartan—type 2 diabetes mellitus	6.78e-05	0.000466	CcSEcCtD
Haloperidol—Urticaria—Irbesartan—type 2 diabetes mellitus	6.76e-05	0.000465	CcSEcCtD
Haloperidol—Headache—Gliclazide—type 2 diabetes mellitus	6.75e-05	0.000464	CcSEcCtD
Haloperidol—Nervous system disorder—Ramipril—type 2 diabetes mellitus	6.73e-05	0.000463	CcSEcCtD
Haloperidol—Body temperature increased—Irbesartan—type 2 diabetes mellitus	6.73e-05	0.000462	CcSEcCtD
Haloperidol—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	6.72e-05	0.000462	CcSEcCtD
Haloperidol—Tachycardia—Ramipril—type 2 diabetes mellitus	6.7e-05	0.000461	CcSEcCtD
Haloperidol—Diarrhoea—Orlistat—type 2 diabetes mellitus	6.7e-05	0.00046	CcSEcCtD
Haloperidol—Skin disorder—Ramipril—type 2 diabetes mellitus	6.67e-05	0.000458	CcSEcCtD
Haloperidol—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	6.64e-05	0.000456	CcSEcCtD
Haloperidol—Feeling abnormal—Losartan—type 2 diabetes mellitus	6.6e-05	0.000453	CcSEcCtD
Haloperidol—Dizziness—Valsartan—type 2 diabetes mellitus	6.55e-05	0.00045	CcSEcCtD
Haloperidol—Anorexia—Ramipril—type 2 diabetes mellitus	6.55e-05	0.00045	CcSEcCtD
Haloperidol—Dizziness—Orlistat—type 2 diabetes mellitus	6.47e-05	0.000445	CcSEcCtD
Haloperidol—Hypotension—Ramipril—type 2 diabetes mellitus	6.42e-05	0.000441	CcSEcCtD
Haloperidol—Nausea—Gliclazide—type 2 diabetes mellitus	6.4e-05	0.00044	CcSEcCtD
Haloperidol—Pruritus—Metformin—type 2 diabetes mellitus	6.38e-05	0.000438	CcSEcCtD
Haloperidol—Urticaria—Losartan—type 2 diabetes mellitus	6.36e-05	0.000437	CcSEcCtD
Haloperidol—Body temperature increased—Losartan—type 2 diabetes mellitus	6.33e-05	0.000435	CcSEcCtD
Haloperidol—Vomiting—Valsartan—type 2 diabetes mellitus	6.3e-05	0.000433	CcSEcCtD
Haloperidol—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	6.27e-05	0.000431	CcSEcCtD
Haloperidol—Rash—Valsartan—type 2 diabetes mellitus	6.24e-05	0.000429	CcSEcCtD
Haloperidol—Dermatitis—Valsartan—type 2 diabetes mellitus	6.24e-05	0.000429	CcSEcCtD
Haloperidol—Vomiting—Orlistat—type 2 diabetes mellitus	6.22e-05	0.000427	CcSEcCtD
Haloperidol—Insomnia—Ramipril—type 2 diabetes mellitus	6.21e-05	0.000427	CcSEcCtD
Haloperidol—Headache—Valsartan—type 2 diabetes mellitus	6.2e-05	0.000426	CcSEcCtD
Haloperidol—Diarrhoea—Metformin—type 2 diabetes mellitus	6.17e-05	0.000424	CcSEcCtD
Haloperidol—Rash—Orlistat—type 2 diabetes mellitus	6.17e-05	0.000424	CcSEcCtD
Haloperidol—Dermatitis—Orlistat—type 2 diabetes mellitus	6.16e-05	0.000424	CcSEcCtD
Haloperidol—Headache—Orlistat—type 2 diabetes mellitus	6.13e-05	0.000421	CcSEcCtD
Haloperidol—Dyspnoea—Ramipril—type 2 diabetes mellitus	6.12e-05	0.000421	CcSEcCtD
Haloperidol—Somnolence—Ramipril—type 2 diabetes mellitus	6.11e-05	0.000419	CcSEcCtD
Haloperidol—Dyspepsia—Ramipril—type 2 diabetes mellitus	6.05e-05	0.000415	CcSEcCtD
Haloperidol—Pruritus—Irbesartan—type 2 diabetes mellitus	6.02e-05	0.000414	CcSEcCtD
Haloperidol—Decreased appetite—Ramipril—type 2 diabetes mellitus	5.97e-05	0.00041	CcSEcCtD
Haloperidol—Dizziness—Metformin—type 2 diabetes mellitus	5.96e-05	0.00041	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	5.93e-05	0.000407	CcSEcCtD
Haloperidol—Hypersensitivity—Losartan—type 2 diabetes mellitus	5.9e-05	0.000405	CcSEcCtD
Haloperidol—Nausea—Valsartan—type 2 diabetes mellitus	5.88e-05	0.000404	CcSEcCtD
Haloperidol—Constipation—Ramipril—type 2 diabetes mellitus	5.87e-05	0.000404	CcSEcCtD
Haloperidol—Diarrhoea—Irbesartan—type 2 diabetes mellitus	5.82e-05	0.0004	CcSEcCtD
Haloperidol—Nausea—Orlistat—type 2 diabetes mellitus	5.81e-05	0.000399	CcSEcCtD
Haloperidol—Vomiting—Metformin—type 2 diabetes mellitus	5.73e-05	0.000394	CcSEcCtD
Haloperidol—Rash—Metformin—type 2 diabetes mellitus	5.69e-05	0.000391	CcSEcCtD
Haloperidol—Dermatitis—Metformin—type 2 diabetes mellitus	5.68e-05	0.00039	CcSEcCtD
Haloperidol—Pruritus—Losartan—type 2 diabetes mellitus	5.67e-05	0.000389	CcSEcCtD
Haloperidol—Feeling abnormal—Ramipril—type 2 diabetes mellitus	5.66e-05	0.000389	CcSEcCtD
Haloperidol—Headache—Metformin—type 2 diabetes mellitus	5.65e-05	0.000388	CcSEcCtD
Haloperidol—Dizziness—Irbesartan—type 2 diabetes mellitus	5.63e-05	0.000387	CcSEcCtD
Haloperidol—Diarrhoea—Losartan—type 2 diabetes mellitus	5.48e-05	0.000377	CcSEcCtD
Haloperidol—Urticaria—Ramipril—type 2 diabetes mellitus	5.46e-05	0.000375	CcSEcCtD
Haloperidol—Body temperature increased—Ramipril—type 2 diabetes mellitus	5.43e-05	0.000373	CcSEcCtD
Haloperidol—Vomiting—Irbesartan—type 2 diabetes mellitus	5.41e-05	0.000372	CcSEcCtD
Haloperidol—Rash—Irbesartan—type 2 diabetes mellitus	5.37e-05	0.000369	CcSEcCtD
Haloperidol—Dermatitis—Irbesartan—type 2 diabetes mellitus	5.36e-05	0.000368	CcSEcCtD
Haloperidol—Nausea—Metformin—type 2 diabetes mellitus	5.36e-05	0.000368	CcSEcCtD
Haloperidol—Headache—Irbesartan—type 2 diabetes mellitus	5.33e-05	0.000366	CcSEcCtD
Haloperidol—Dizziness—Losartan—type 2 diabetes mellitus	5.3e-05	0.000364	CcSEcCtD
Haloperidol—Vomiting—Losartan—type 2 diabetes mellitus	5.09e-05	0.00035	CcSEcCtD
Haloperidol—Hypersensitivity—Ramipril—type 2 diabetes mellitus	5.06e-05	0.000348	CcSEcCtD
Haloperidol—Nausea—Irbesartan—type 2 diabetes mellitus	5.06e-05	0.000347	CcSEcCtD
Haloperidol—Rash—Losartan—type 2 diabetes mellitus	5.05e-05	0.000347	CcSEcCtD
Haloperidol—Dermatitis—Losartan—type 2 diabetes mellitus	5.05e-05	0.000347	CcSEcCtD
Haloperidol—Headache—Losartan—type 2 diabetes mellitus	5.02e-05	0.000345	CcSEcCtD
Haloperidol—Pruritus—Ramipril—type 2 diabetes mellitus	4.86e-05	0.000334	CcSEcCtD
Haloperidol—Nausea—Losartan—type 2 diabetes mellitus	4.76e-05	0.000327	CcSEcCtD
Haloperidol—Diarrhoea—Ramipril—type 2 diabetes mellitus	4.7e-05	0.000323	CcSEcCtD
Haloperidol—Dizziness—Ramipril—type 2 diabetes mellitus	4.54e-05	0.000312	CcSEcCtD
Haloperidol—Vomiting—Ramipril—type 2 diabetes mellitus	4.37e-05	0.0003	CcSEcCtD
Haloperidol—Rash—Ramipril—type 2 diabetes mellitus	4.33e-05	0.000298	CcSEcCtD
Haloperidol—Dermatitis—Ramipril—type 2 diabetes mellitus	4.33e-05	0.000297	CcSEcCtD
Haloperidol—Headache—Ramipril—type 2 diabetes mellitus	4.3e-05	0.000296	CcSEcCtD
Haloperidol—Nausea—Ramipril—type 2 diabetes mellitus	4.08e-05	0.00028	CcSEcCtD
Haloperidol—HTR2B—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.76e-06	1.77e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.76e-06	1.77e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—INS—type 2 diabetes mellitus	1.76e-06	1.76e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	1.76e-06	1.76e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.76e-06	1.76e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	1.75e-06	1.76e-05	CbGpPWpGaD
Haloperidol—DRD3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.75e-06	1.76e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—INS—type 2 diabetes mellitus	1.75e-06	1.76e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	1.75e-06	1.76e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.75e-06	1.75e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.74e-06	1.75e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	1.74e-06	1.74e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.74e-06	1.74e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.73e-06	1.74e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—SRC—type 2 diabetes mellitus	1.73e-06	1.74e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.73e-06	1.73e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.73e-06	1.73e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.72e-06	1.73e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.72e-06	1.73e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.72e-06	1.73e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	1.72e-06	1.73e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.72e-06	1.73e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.72e-06	1.72e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.71e-06	1.72e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—SRC—type 2 diabetes mellitus	1.7e-06	1.71e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	1.7e-06	1.71e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	1.7e-06	1.71e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.7e-06	1.7e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.7e-06	1.7e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	1.7e-06	1.7e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.69e-06	1.7e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.69e-06	1.7e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.69e-06	1.7e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	1.69e-06	1.69e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—PPARG—type 2 diabetes mellitus	1.69e-06	1.69e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.69e-06	1.69e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.69e-06	1.69e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	1.68e-06	1.69e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	1.67e-06	1.68e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	1.67e-06	1.68e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	1.67e-06	1.68e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	1.67e-06	1.67e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.66e-06	1.67e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	1.66e-06	1.67e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.66e-06	1.66e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—INS—type 2 diabetes mellitus	1.65e-06	1.66e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	1.65e-06	1.66e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.64e-06	1.65e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.64e-06	1.65e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	1.64e-06	1.64e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.64e-06	1.64e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	1.64e-06	1.64e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	1.63e-06	1.64e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	1.63e-06	1.63e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—SRC—type 2 diabetes mellitus	1.63e-06	1.63e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	1.62e-06	1.63e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.62e-06	1.63e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	1.62e-06	1.62e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.62e-06	1.62e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	1.62e-06	1.62e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	1.62e-06	1.62e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.61e-06	1.62e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.61e-06	1.62e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	1.61e-06	1.62e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.61e-06	1.61e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	1.6e-06	1.61e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.59e-06	1.6e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	1.59e-06	1.6e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	1.59e-06	1.59e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	1.59e-06	1.59e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	1.58e-06	1.59e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.58e-06	1.59e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.58e-06	1.58e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	1.58e-06	1.58e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	1.57e-06	1.57e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	1.56e-06	1.57e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.56e-06	1.57e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.56e-06	1.57e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	1.55e-06	1.56e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	1.55e-06	1.56e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.55e-06	1.55e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.55e-06	1.55e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	1.55e-06	1.55e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	1.54e-06	1.55e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.54e-06	1.54e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.54e-06	1.54e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.54e-06	1.54e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.54e-06	1.54e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	1.54e-06	1.54e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	1.53e-06	1.54e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	1.53e-06	1.54e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.53e-06	1.54e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	1.53e-06	1.53e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	1.53e-06	1.53e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.52e-06	1.53e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	1.52e-06	1.53e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.52e-06	1.52e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—ALB—type 2 diabetes mellitus	1.52e-06	1.52e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—SRC—type 2 diabetes mellitus	1.51e-06	1.52e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	1.51e-06	1.52e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	1.51e-06	1.52e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	1.5e-06	1.51e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.49e-06	1.5e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.49e-06	1.5e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	1.49e-06	1.49e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	1.47e-06	1.48e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.47e-06	1.48e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.47e-06	1.48e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	1.47e-06	1.48e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	1.46e-06	1.47e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	1.46e-06	1.46e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.45e-06	1.46e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.45e-06	1.45e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—NOS3—type 2 diabetes mellitus	1.45e-06	1.45e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	1.45e-06	1.45e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.45e-06	1.45e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	1.45e-06	1.45e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	1.45e-06	1.45e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.45e-06	1.45e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	1.44e-06	1.45e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	1.44e-06	1.45e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	1.44e-06	1.44e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	1.44e-06	1.44e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	1.43e-06	1.43e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.42e-06	1.43e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	1.4e-06	1.41e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	1.4e-06	1.4e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.38e-06	1.39e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	1.38e-06	1.38e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.37e-06	1.37e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	1.35e-06	1.36e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.35e-06	1.36e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	1.35e-06	1.35e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.34e-06	1.35e-05	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.34e-06	1.35e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.33e-06	1.33e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—PTGS2—type 2 diabetes mellitus	1.33e-06	1.33e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	1.33e-06	1.33e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.33e-06	1.33e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—INS—type 2 diabetes mellitus	1.32e-06	1.33e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.32e-06	1.32e-05	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.32e-06	1.32e-05	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.32e-06	1.32e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.31e-06	1.31e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.3e-06	1.31e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	1.3e-06	1.3e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.3e-06	1.3e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.3e-06	1.3e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	1.27e-06	1.27e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	1.26e-06	1.26e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	1.26e-06	1.26e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.26e-06	1.26e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.25e-06	1.25e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.25e-06	1.25e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.24e-06	1.25e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.24e-06	1.25e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.24e-06	1.25e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	1.24e-06	1.24e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	1.24e-06	1.24e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.24e-06	1.24e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	1.23e-06	1.24e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	1.23e-06	1.24e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.23e-06	1.24e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.23e-06	1.23e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.22e-06	1.23e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	1.22e-06	1.22e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.22e-06	1.22e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.22e-06	1.22e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	1.21e-06	1.21e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.2e-06	1.2e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.2e-06	1.2e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—IL6—type 2 diabetes mellitus	1.19e-06	1.19e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.19e-06	1.19e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	1.19e-06	1.19e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	1.19e-06	1.19e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—IL6—type 2 diabetes mellitus	1.17e-06	1.17e-05	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—AKT1—type 2 diabetes mellitus	1.16e-06	1.16e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.16e-06	1.16e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	1.16e-06	1.16e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.16e-06	1.16e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.16e-06	1.16e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—IL6—type 2 diabetes mellitus	1.15e-06	1.15e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	1.14e-06	1.14e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.14e-06	1.14e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.14e-06	1.14e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.14e-06	1.14e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	1.13e-06	1.13e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.13e-06	1.13e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.11e-06	1.12e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.11e-06	1.11e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.11e-06	1.11e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.11e-06	1.11e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.1e-06	1.1e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—IL6—type 2 diabetes mellitus	1.09e-06	1.1e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	1.09e-06	1.1e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.09e-06	1.1e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	1.09e-06	1.09e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.08e-06	1.09e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	1.08e-06	1.09e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.08e-06	1.08e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.08e-06	1.08e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	1.07e-06	1.08e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.07e-06	1.07e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	1.06e-06	1.06e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.06e-06	1.06e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	1.05e-06	1.06e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.03e-06	1.04e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.03e-06	1.04e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.02e-06	1.03e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—IL6—type 2 diabetes mellitus	1.02e-06	1.02e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.02e-06	1.02e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.02e-06	1.02e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.01e-06	1.02e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.01e-06	1.01e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1e-06	1.01e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	9.98e-07	1e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.98e-07	1e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.96e-07	9.99e-06	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	9.9e-07	9.93e-06	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—AKT1—type 2 diabetes mellitus	9.76e-07	9.79e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	9.72e-07	9.75e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	9.67e-07	9.7e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	9.56e-07	9.59e-06	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.53e-07	9.56e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	9.52e-07	9.56e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	9.42e-07	9.45e-06	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.4e-07	9.43e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	9.25e-07	9.28e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	9.25e-07	9.28e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	8.46e-07	8.48e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	8.3e-07	8.32e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	8.14e-07	8.16e-06	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—IL6—type 2 diabetes mellitus	7.8e-07	7.82e-06	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—IL6—type 2 diabetes mellitus	7.67e-07	7.7e-06	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—IL6—type 2 diabetes mellitus	7.65e-07	7.68e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	7.46e-07	7.48e-06	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.19e-07	7.22e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	7.14e-07	7.16e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	7.14e-07	7.16e-06	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.08e-07	7.1e-06	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.06e-07	7.08e-06	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	7.06e-07	7.08e-06	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—AKT1—type 2 diabetes mellitus	6.67e-07	6.69e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	6.53e-07	6.55e-06	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	5.45e-07	5.47e-06	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	5.32e-07	5.34e-06	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	5.02e-07	5.03e-06	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	4.97e-07	4.99e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	4.25e-07	4.26e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	3.28e-07	3.29e-06	CbGpPWpGaD
